Ravindra Kumar, VP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 5,500 shares at $38.56 ($213K) on 2015-02-02, disclosed to the SEC on 2015-02-04.
Scheduled sale ($213k) by VP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.39 | 2,565 | $98K | 46.3% |
| 2 | $38.56 | 1,200 | $46K | 21.8% |
| 3 | $39.13 | 1,435 | $56K | 26.4% |
| 4 | $39.46 | 300 | $12K | 5.6% |
| Total | $38.68 avg | 5,500 | $213K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |